Pharmacovigilance related activities of Member States and the European Medicines Agency concerning medicinal products for human use (2012 – 2014)European Observatory on Health Systems and PoliciesHST General
World Health OrganizationHST General
Saving Mothers 2011-2013: Sixth report on the Confidential Enquiries into Maternal Deaths in South AfricaDepartment of Health (South Africa)HST General
Department of Health (South Africa)Non HST
Standard Treatment Guidelines and Essential Drugs List Primary Health Care
These initial products cover common health problems and drugs lists at secondary and tertiary hospital level. There were problem areas, where common conditions arise by concentration and are complicated, problematic, essentially rare, expensive to diagnose and to treat and require complicated procedures. Such conditions, e.g. onco-therapy, dialysis, transplantation, and HIV/AIDS, require special mention and attention at a different level. A next stage would be to consider the appointment of panels of experts, guided by health authority policies, to develop protocols, covering all aspects, including cost implications, palliation, treatment, prognosis, selection criteria and mechanisms of funding.
Hopefully the completed initial step will facilitate the development of rational prescribing and dispensing, eliminate wastage, encourage research and critical evaluation and facilitate equity in health care.